Theriva Biologics, Inc. (TOVX) stock
TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.14+0.00 (0.00%)
Close on Nov 17, 2026Market cap $6.42MP/E –Yield –
Theriva Biologics total assets
Total assets on the balance sheet at the end of each period.
Theriva Biologics's total assets was $34.86M at Jun 30, 2026. For fiscal 2025 it was $38.24M, up 8.2% from the year before. Over ten years it grew 2.2% a year on average. The highest annual figure on record is $71.86M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.24M | +8.2% |
| FY2024 | Dec 31, 2024 | $35.35M | -36.0% |
| FY2023 | Dec 31, 2023 | $55.22M | -23.2% |
| FY2022 | Dec 31, 2022 | $71.86M | +2.1% |
| FY2021 | Dec 31, 2021 | $70.37M | +736.7% |
| FY2020 | Dec 31, 2020 | $8.41M | -51.2% |
| FY2019 | Dec 31, 2019 | $17.24M | -42.8% |
| FY2018 | Dec 31, 2018 | $30.14M | +60.0% |
| FY2017 | Dec 31, 2017 | $18.84M | -16.3% |
| FY2016 | Dec 31, 2016 | $22.50M | -27.1% |
| FY2015 | Dec 31, 2015 | $30.85M | +61.1% |
| FY2014 | Dec 31, 2014 | $19.14M | +17.8% |
| FY2013 | Dec 31, 2013 | $16.26M | +21.1% |
| FY2012 | Dec 31, 2012 | $13.42M | +79.5% |
| FY2011 | Dec 31, 2011 | $7.48M | +81.9% |
| FY2010 | Dec 31, 2010 | $4.11M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $34.86M | -2.7% |
| Q1 FY2026 | Mar 31, 2026 | $38.25M | +18.9% |
| Q4 FY2025 | Dec 31, 2025 | $38.24M | +8.2% |
| Q3 FY2025 | Sep 30, 2025 | $30.84M | -23.1% |
| Q2 FY2025 | Jun 30, 2025 | $35.83M | -15.5% |
| Q1 FY2025 | Mar 31, 2025 | $32.16M | -34.0% |
| Q4 FY2024 | Dec 31, 2024 | $35.35M | -36.0% |
| Q3 FY2024 | Sep 30, 2024 | $40.11M | -34.8% |
| Q2 FY2024 | Jun 30, 2024 | $42.39M | -35.2% |
| Q1 FY2024 | Mar 31, 2024 | $48.73M | -28.2% |
| Q4 FY2023 | Dec 31, 2023 | $55.22M | -23.2% |
| Q3 FY2023 | Sep 30, 2023 | $61.55M | -20.2% |
| Q2 FY2023 | Jun 30, 2023 | $65.45M | -18.8% |
| Q1 FY2023 | Mar 31, 2023 | $67.89M | -23.7% |
| Q4 FY2022 | Dec 31, 2022 | $71.86M | +2.1% |
| Q3 FY2022 | Sep 30, 2022 | $77.11M | +2.7% |
| Q2 FY2022 | Jun 30, 2022 | $80.64M | +4.4% |
| Q1 FY2022 | Mar 31, 2022 | $89.00M | +12.6% |
| Q4 FY2021 | Dec 31, 2021 | $70.37M | +736.7% |
| Q3 FY2021 | Sep 30, 2021 | $75.12M | +942.9% |
| Q2 FY2021 | Jun 30, 2021 | $77.26M | +706.3% |
| Q1 FY2021 | Mar 31, 2021 | $79.05M | +565.0% |
| Q4 FY2020 | Dec 31, 2020 | $8.41M | -51.2% |
| Q3 FY2020 | Sep 30, 2020 | $7.20M | -65.3% |
| Q2 FY2020 | Jun 30, 2020 | $9.58M | -60.1% |
| Q1 FY2020 | Mar 31, 2020 | $11.89M | -55.4% |
| Q4 FY2019 | Dec 31, 2019 | $17.24M | -42.8% |
| Q3 FY2019 | Sep 30, 2019 | $20.74M | +92.1% |
| Q2 FY2019 | Jun 30, 2019 | $24.00M | +185.1% |
| Q1 FY2019 | Mar 31, 2019 | $26.63M | +113.6% |
| Q4 FY2018 | Dec 31, 2018 | $30.14M | +60.0% |
| Q3 FY2018 | Sep 30, 2018 | $10.80M | -53.6% |
| Q2 FY2018 | Jun 30, 2018 | $8.42M | -46.5% |
| Q1 FY2018 | Mar 31, 2018 | $12.47M | -29.6% |
| Q4 FY2017 | Dec 31, 2017 | $18.84M | -16.3% |
| Q3 FY2017 | Sep 30, 2017 | $23.28M | +182.2% |
| Q2 FY2017 | Jun 30, 2017 | $15.74M | – |
| Q1 FY2017 | Mar 31, 2017 | $17.72M | – |
| Q4 FY2016 | Dec 31, 2016 | $22.50M | – |
| Q3 FY2016 | Sep 30, 2016 | $8.25M | – |
See a number that looks wrong?